GAVI Commits to Funding for Pneumococcal & Rotavirus Vaccines

December 04, 2006

At its latest meeting, the GAVI Alliance board committed $200 million to support the introduction of new vaccines against rotavirus and pneumococcal disease in developing countries; the Washington Post subsequently ran an editorial in support of the decision.


CGD blog posts reflect the views of the authors, drawing on prior research and experience in their areas of expertise. CGD is a nonpartisan, independent organization and does not take institutional positions.